United States · Bill · HR
H.R. 1825 (118th)
Right to Try Clarification Act
Introduced
28 March 2023
Last action
7 April 2023 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Earl Blumenauer, Rep. Mace, Nancy [R-SC-1], Rep. Dean, Madeleine [D-PA-4], Rep. Biggs, Andy [R-AZ-5], Rep. Correa, J. Luis [D-CA-46]
Subjects
Healthcare
Source updated
24 July 2024
Summary
Right to Try Clarification Act This bill specifies that investigational drugs that are provided via the Right to Try pathway are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances). The Right to Try pathway allows drug manufacturers to provide certain investigational drugs for which a Phase I clinical trial has been completed, but that have not yet received approval from the Food and Drug Administration, directly to individuals who have imminently life-threatening diseases or conditions and who have exhausted other treatment options and are unable to participate in clinical trials.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 March 2023
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
28 March 2023
Introduced
Sponsor introductory remarks on measure. (CR E267)
Source: IntroReferral
28 March 2023
Introduced
Introduced in House
Source: IntroReferral
28 March 2023
Introduced
Introduced in House
Source: IntroReferral
7 April 2023
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 28 March 2023 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 28 March 2023
Introduced in House (PDF)
Introduced in House · EN · 28 March 2023
Introduced in House
summary · EN · 28 March 2023
Sponsors
- Earl Blumenauer · D · Sponsor
- Rep. Mace, Nancy [R-SC-1] · R · Sponsor
- Rep. Dean, Madeleine [D-PA-4] · D · Sponsor
- Rep. Biggs, Andy [R-AZ-5] · R · Sponsor
- Rep. Correa, J. Luis [D-CA-46] · D · Sponsor
- · hsif00 · Standing
- · hsju00 · Standing
Related records
- related to ← Right to Try Clarification Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/1825
- Open data entity: https://api.congress.gov/v3/bill/118/hr/1825
- us · 118-hr-1825 · source updated 24 July 2024